{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:14:54Z","timestamp":1775092494775,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00198-014-2678-5","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T05:17:02Z","timestamp":1397107022000},"page":"1735-1750","source":"Crossref","is-referenced-by-count":22,"title":["Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass"],"prefix":"10.1007","volume":"25","author":[{"given":"S. K.","family":"Amugongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-A. E.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. K. N.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Panganiban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. O.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"2678_CR1","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1002\/jbmr.446","volume":"26","author":"DC Mackey","year":"2011","unstructured":"Mackey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P, Thompson JR, Cummings SR (2011) Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res: Off J Am Soc Bone Miner Res 26:2411\u20132418","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"2678_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","volume":"112","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281\u2013289","journal-title":"Am J Med"},{"key":"2678_CR4","doi-asserted-by":"crossref","unstructured":"Cosman F, Keaveny TM, Kopperdahl D, Wermers RA, Wan X, Krohn KD, Krege JH (2014) Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (in press)","DOI":"10.1002\/jbmr.1853"},{"key":"2678_CR5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","volume":"350","author":"R Lindsay","year":"1997","unstructured":"Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F (1997) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550\u2013555","journal-title":"Lancet"},{"key":"2678_CR6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00198-012-2098-3","volume":"24","author":"DM Black","year":"2012","unstructured":"Black DM, Bilezikian JP, Greenspan SL, Wuster C, Munoz-Torres M, Bone HG, Rosen CJ, Andersen HS, Hanley DA (2012) Improved adherence with PTH(1-84) in an extension trial for 24\u00a0months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis. Osteoporos Int: J Established Result Cooper Bet Eur Found Osteoporos Natl Osteoporos Found USA 24:1503\u20131511","journal-title":"Osteoporos Int: J Established Result Cooper Bet Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"2678_CR7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","volume":"353","author":"DM Black","year":"2005","unstructured":"Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, Lang TF, McGowan JA, Rosen CJ (2005) One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med 353:555\u2013565","journal-title":"N Engl J Med"},{"key":"2678_CR8","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1359\/jbmr.080805","volume":"23","author":"TM Keaveny","year":"2008","unstructured":"Keaveny TM, Hoffmann PF, Singh M, Palermo L, Bilezikian JP, Greenspan SL, Black DM (2008) Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res: Off J Am Soc Bone Miner Res 23:1974\u20131982","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","volume":"19","author":"B Ettinger","year":"2004","unstructured":"Ettinger B, San Martin J, Crans G, Pavo I (2004) Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Min Res: Off J Am Soc Bone Miner Res 19:745\u2013751","journal-title":"J Bone Min Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR10","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1210\/jc.2008-2719","volume":"94","author":"F Cosman","year":"2009","unstructured":"Cosman F, Wermers RA, Recknor C, Mauck KF, Xie L, Glass EV, Krege JH (2009) Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent. J Clin Endocrinol Metab 94:3772\u20133780","journal-title":"J Clin Endocrinol Metab"},{"key":"2678_CR11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1359\/jbmr.081250","volume":"24","author":"F Cosman","year":"2009","unstructured":"Cosman F, Nieves JW, Zion M, Barbuto N, Lindsay R (2009) Retreatment with teriparatide one year after the first teriparatide course in patients on continued long-term alendronate. J Bone Miner Res: Off J Am Soc Bone Miner Res 24:1110\u20131115","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00198-004-1636-z","volume":"15","author":"ES Kurland","year":"2004","unstructured":"Kurland ES, Heller SL, Diamond B, McMahon DJ, Cosman F, Bilezikian JP (2004) The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1\u201334)]. Osteoporos Int: J established Result Cooper Bet Eur Found Osteoporo Natl Osteoporos Found USA 15:992\u2013997","journal-title":"Osteoporos Int: J established Result Cooper Bet Eur Found Osteoporo Natl Osteoporos Found USA"},{"key":"2678_CR13","first-page":"2129","volume":"85","author":"RS Rittmaster","year":"2000","unstructured":"Rittmaster RS, Bolognese M, Ettinger MP, Hanley DA, Hodsman AB, Kendler DL, Rosen CJ (2000) Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab 85:2129\u20132134","journal-title":"J Clin Endocrinol Metab"},{"key":"2678_CR14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/JBMR.040123","volume":"19","author":"Y Rhee","year":"2004","unstructured":"Rhee Y, Won YY, Baek MH, Lim SK (2004) Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats. J Bone Miner Res: Off J Am Soc Bone Miner Res 19:931\u2013937","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinthera.2004.12.020","volume":"27","author":"D Felsenberg","year":"2005","unstructured":"Felsenberg D, Boonen S (2005) The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther 27:1\u201311","journal-title":"Clin Ther"},{"key":"2678_CR16","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI118289","volume":"96","author":"V Shen","year":"1995","unstructured":"Shen V, Birchman R, Xu R, Otter M, Wu D, Lindsay R, Dempster DW (1995) Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats. J Clin Investig 96:2331\u20132338","journal-title":"J Clin Investig"},{"key":"2678_CR17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S8756-3282(01)00582-8","volume":"29","author":"UT Iwaniec","year":"2001","unstructured":"Iwaniec UT, Samnegard E, Cullen DM, Kimmel DB (2001) Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. Bone 29:352\u2013360","journal-title":"Bone"},{"key":"2678_CR18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S8756-3282(01)00408-2","volume":"28","author":"E Samnegard","year":"2001","unstructured":"Samnegard E, Akhter MP, Recker RR (2001) Maintenance of vertebral body bone mass and strength created by human parathyroid hormone treatment in ovariectomized rats. Bone 28:414\u2013422","journal-title":"Bone"},{"key":"2678_CR19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/8756-3282(95)00115-T","volume":"16","author":"M Li","year":"1995","unstructured":"Li M, Mosekilde L, Sogaard CH, Thomsen JS, Wronski TJ (1995) Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Bone 16:629\u2013635","journal-title":"Bone"},{"key":"2678_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","volume":"93","author":"LJ Black","year":"1994","unstructured":"Black LJ, Sato M, Rowley ER et al (1994) Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Investig 93:63\u201369","journal-title":"J Clin Investig"},{"key":"2678_CR21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jbmr.5650060405","volume":"6","author":"JG Seedor","year":"1991","unstructured":"Seedor JG, Quartuccio HA, Thompson DD (1991) The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J Bone Miner Res: Off J Am Soc Bone Miner Res 6:339\u2013346","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR22","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res: Off J Am Soc Bone Miner Res 25:1468\u20131486","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR23","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"DM Black","year":"2006","unstructured":"Black DM, Schwartz AV, Ensrud KE et al (2006) Effects of continuing or stopping alendronate after 5\u00a0years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA: J Am Med Assoc 296:2927\u20132938","journal-title":"JAMA: J Am Med Assoc"},{"key":"2678_CR24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","volume":"282","author":"B Ettinger","year":"1999","unstructured":"Ettinger B, Black DM, Mitlak BH et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA: J Am Med Assoc 282:637\u2013645","journal-title":"JAMA: J Am Med Assoc"},{"key":"2678_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jocd.2008.10.006","volume":"12","author":"RR Recker","year":"2009","unstructured":"Recker RR, Ste-Marie LG, Langdahl B, Masanauskaite D, Ethgen D, Delmas PD (2009) Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study. J Clin Densitom: Off J Int Soc Clin Densitom 12:71\u201376","journal-title":"J Clin Densitom: Off J Int Soc Clin Densitom"},{"key":"2678_CR26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bone.2007.06.021","volume":"41","author":"W Yao","year":"2007","unstructured":"Yao W, Cheng Z, Koester KJ, Ager JW, Balooch M, Pham A, Chefo S, Busse C, Ritchie RO, Lane NE (2007) The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength. Bone 41:804\u2013812","journal-title":"Bone"},{"key":"2678_CR27","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bone.2003.08.004","volume":"33","author":"DB Burr","year":"2003","unstructured":"Burr DB, Miller L, Grynpas M, Li J, Boyde A, Mashiba T, Hirano T, Johnston CC (2003) Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. Bone 33:960\u2013969","journal-title":"Bone"},{"key":"2678_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00198-011-1758-z","volume":"23","author":"R Rizzoli","year":"2012","unstructured":"Rizzoli R, Chapurlat RD, Laroche JM, Krieg MA, Thomas T, Frieling I, Boutroy S, Laib A, Bock O, Felsenberg D (2012) Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study. Osteoporos Int: J Established Result Cooper Bet Eur Found Osteoporos Natl Osteoporos Found USA 23:305\u2013315","journal-title":"Osteoporos Int: J Established Result Cooper Bet Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"2678_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","volume":"126","author":"M McClung","year":"2013","unstructured":"McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM (2013) Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 126:13\u201320","journal-title":"Am J Med"},{"key":"2678_CR30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11914-012-0129-9","volume":"11","author":"C Ro","year":"2013","unstructured":"Ro C, Cooper O (2013) Bisphosphonate drug holiday: choosing appropriate candidates. Curr Osteoporos Rep 11:45\u201351","journal-title":"Curr Osteoporos Rep"},{"key":"2678_CR31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1359\/jbmr.81005","volume":"24","author":"Z Cheng","year":"2009","unstructured":"Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE (2009) Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. J Bone Miner Res: Off J Am Soc Bone Miner Res 24:209\u2013220","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jbmr.5650110205","volume":"11","author":"Y Takano","year":"1996","unstructured":"Takano Y, Tanizawa T, Mashiba T, Endo N, Nishida S, Takahashi HE (1996) Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1\u201334) administration in ovariectomized rats. J Bone Miner Res: Off J Am Soc Bone Miner Res 11:169\u2013177","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bone.2007.07.005","volume":"41","author":"W Yao","year":"2007","unstructured":"Yao W, Su M, Zhang Q, Tian X, Setterberg RB, Blanton C, Lundy MW, Phipps R, Jee WS (2007) Risedronate did not block the maximal anabolic effect of PTH in aged rats. Bone 41:813\u2013819","journal-title":"Bone"},{"key":"2678_CR34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S8756-3282(99)00015-0","volume":"24","author":"AB Hodsman","year":"1999","unstructured":"Hodsman AB, Watson PH, Drost D, Holdsworth D, Thornton M, Hock J, Bryant H, Fraher LJ (1999) Assessment of maintenance therapy with reduced doses of PTH(1\u201334) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat. Bone 24:451\u2013455","journal-title":"Bone"},{"key":"2678_CR35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bone.2005.09.019","volume":"38","author":"M Stauber","year":"2006","unstructured":"Stauber M, Muller R (2006) Volumetric spatial decomposition of trabecular bone into rods and plates\u2013a new method for local bone morphometry. Bone 38:475\u2013484","journal-title":"Bone"},{"key":"2678_CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/01495739708936692","volume":"1","author":"T Hildebrand","year":"1997","unstructured":"Hildebrand T, Ruegsegger P (1997) Quantification of bone microarchitecture with the Structure Model Index. Comput Methods Biomech Biomed Eng 1:15\u201323","journal-title":"Comput Methods Biomech Biomed Eng"},{"issue":"Suppl","key":"2678_CR37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03026336","volume":"23","author":"Y Jiang","year":"2005","unstructured":"Jiang Y, Zhao J, Liao EY, Dai RC, Wu XP, Genant HK (2005) Application of micro-CT assessment of 3-D bone microstructure in preclinical and clinical studies. J Bone Miner Metab 23(Suppl):122\u2013131","journal-title":"J Bone Miner Metab"},{"key":"2678_CR38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bone.2008.09.019","volume":"44","author":"RR Recker","year":"2009","unstructured":"Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J (2009) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1\u201384. Bone 44:113\u2013119","journal-title":"Bone"},{"key":"2678_CR39","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1359\/jbmr.080517","volume":"23","author":"ME Arlot","year":"2008","unstructured":"Arlot ME, Burt-Pichat B, Roux JP, Vashishth D, Bouxsein ML, Delmas PD (2008) Microarchitecture influences microdamage accumulation in human vertebral trabecular bone. J Bone Miner Res: Off J Am Soc Bone Miner Res 23:1613\u20131618","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR40","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00198-009-0882-5","volume":"20","author":"JE Brouwers","year":"2009","unstructured":"Brouwers JE, van Rietbergen B, Huiskes R, Ito K (2009) Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT. Osteoporos Int: J Established Result Cooper Bet Eur Found Osteoporos Natl Osteoporos Found USA 20:1823\u20131835","journal-title":"Osteoporos Int: J Established Result Cooper Bet Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"2678_CR41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00223-007-9084-3","volume":"82","author":"JE Brouwers","year":"2008","unstructured":"Brouwers JE, Lambers FM, Gasser JA, van Rietbergen B, Huiskes R (2008) Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography. Calcif Tissue Int 82:202\u2013211","journal-title":"Calcif Tissue Int"},{"key":"2678_CR42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bone.2003.12.013","volume":"34","author":"B Borah","year":"2004","unstructured":"Borah B, Dufresne TE, Chmielewski PA, Johnson TD, Chines A, Manhart MD (2004) Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. Bone 34:736\u2013746","journal-title":"Bone"},{"key":"2678_CR43","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S8756-3282(02)00684-1","volume":"30","author":"M Ito","year":"2002","unstructured":"Ito M, Nishida A, Nakamura T, Uetani M, Hayashi K (2002) Differences of three-dimensional trabecular microstructure in osteopenic rat models caused by ovariectomy and neurectomy. Bone 30:594\u2013598","journal-title":"Bone"},{"key":"2678_CR44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clinbiomech.2005.11.001","volume":"21","author":"JC Teo","year":"2006","unstructured":"Teo JC, Si-Hoe KM, Keh JE, Teoh SH (2006) Relationship between CT intensity, micro-architecture and mechanical properties of porcine vertebral cancellous bone. Clin Biomech (Bristol, Avon) 21:235\u2013244","journal-title":"Clin Biomech (Bristol, Avon)"},{"key":"2678_CR45","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1359\/jbmr.090317","volume":"24","author":"AJ Fields","year":"2009","unstructured":"Fields AJ, Eswaran SK, Jekir MG, Keaveny TM (2009) Role of trabecular microarchitecture in whole-vertebral body biomechanical behavior. J Bone Miner Res: Off J Am Soc Bone Miner Res 24:1523\u20131530","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"2678_CR46","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-009-1047-2","volume":"21","author":"LJ Melton 3rd","year":"2010","unstructured":"Melton LJ 3rd, Christen D, Riggs BL, Achenbach SJ, Muller R, van Lenthe GH, Amin S, Atkinson EJ, Khosla S (2010) Assessing forearm fracture risk in postmenopausal women. Osteoporos Int: J Established Result Cooper Bet Eur Found Osteoporos Natl Osteoporos Found USA 21:1161\u20131169","journal-title":"Osteoporos Int: J Established Result Cooper Bet Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"2678_CR47","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/jor.20913","volume":"27","author":"JE Brouwers","year":"2009","unstructured":"Brouwers JE, Lambers FM, van Rietbergen B, Ito K, Huiskes R (2009) Comparison of bone loss induced by ovariectomy and neurectomy in rats analyzed by in vivo micro-CT. J Orthop Res: Off Publ Orthop Res Soc 27:1521\u20131527","journal-title":"J Orthop Res: Off Publ Orthop Res Soc"},{"key":"2678_CR48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00223-006-0108-1","volume":"79","author":"J Fox","year":"2006","unstructured":"Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY (2006) Daily treatment of aged ovariectomized rats with human parathyroid hormone (1\u201384) for 12\u00a0months reverses bone loss and enhances trabecular and cortical bone strength. Calcif Tissue Int 79:262\u2013272","journal-title":"Calcif Tissue Int"},{"key":"2678_CR49","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1359\/jbmr.070728","volume":"22","author":"LJ Melton 3rd","year":"2007","unstructured":"Melton LJ 3rd, Riggs BL, Keaveny TM et al (2007) Structural determinants of vertebral fracture risk. J Bone Miner Res: Off J Am Soc Bone Miner Res 22:1885\u20131892","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2678-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2678-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T07:18:23Z","timestamp":1565335103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-014-2678-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1007\/s00198-014-2678-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]}}}